相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emodin regulates cell cycle of non-small lung cancer (NSCLC) cells through hyaluronan synthase 2 (HA2)-HA-CD44/receptor for hyaluronic acid-mediated motility (RHAMM) interaction-dependent signaling pathway
Mingzhu Li et al.
CANCER CELL INTERNATIONAL (2021)
pH-sensitive chitosan nanoparticles loaded with dolutegravir as milk and food admixture for paediatric anti-HIV therapy
K. Priya Dharshini et al.
CARBOHYDRATE POLYMERS (2021)
An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway
Xiaomeng Ren et al.
ACTA BIOMATERIALIA (2021)
Cu-MOF chemodynamic nanoplatform via modulating glutathione and H2O2 in tumor microenvironment for amplified cancer therapy
Hailong Tian et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2021)
A two-pronged photodynamic nanodrug to prevent metastasis of basal-like breast cancer
Jing Zhang et al.
CHEMICAL COMMUNICATIONS (2021)
Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation
Yaxin Zhou et al.
NANOSCALE HORIZONS (2021)
Ultrasmall TPGS-PLGA Hybrid Nanoparticles for Site-Specific Delivery of Antibiotics into Pseudomonas aeruginosa Biofilms in Lungs
Feng Wan et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Clinical Pharmacokinetics and Pharmacodynamics of Dasatinib
Dominique Leveque et al.
CLINICAL PHARMACOKINETICS (2020)
Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells
Ran Tao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Delivery of thymoquinone through hyaluronic acid-decorated mixed Pluronic® nanoparticles to attenuate angiogenesis and metastasis of triple-negative breast cancer
Saurav Bhattacharya et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer
Cheng Xu et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an in-vitro, in-vivo and mechanistic investigation
Lalit Mohan Negi et al.
JOURNAL OF DRUG TARGETING (2019)
CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment
A. Tirella et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Tumor-targeted drug delivery and sensitization by MMP2-responsive polymeric micelles
Qing Yao et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Verapamil delivery systems on the basis of mesoporous ZSM-5/KIT-6 and ZSM-5/SBA-15 polymer nanocomposites as a potential tool to overcome MDR in cancer cells
Margarita Popova et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Poly(Cyclohexene Phthalate) Nanoparticles for Controlled Dasatinib Delivery in Breast Cancer Therapy
Enrique Niza et al.
NANOMATERIALS (2019)
Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles
Jie Gao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Preparation and in vitro evaluation of radiolabeled HA-PLGA nanoparticles as novel MTX delivery system for local treatment of rheumatoid arthritis
R. Maydelid Trujillo-Nolasco et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Tumoral Acidic pH-Responsive cis-Diaminodichloroplatinum-Incorporated Cy5.5-PEG-g-A-HA Nanoparticles for Targeting Delivery of CDDP against Cervical Cancer
Cui Cheng et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Epidermal Growth Factor Receptor-Targeting Peptide Nanoparticles Simultaneously Deliver Gemcitabine and Olaparib To Treat Pancreatic Cancer with Breast Cancer 2 (BRCA2) Mutation
Chong Du et al.
ACS NANO (2018)
Tumor-Specific Multiple Stimuli-Activated Dendrimeric Nanoassemblies with Metabolic Blockade Surmount Chemotherapy Resistance
Yachao Li et al.
ACS NANO (2017)
pH-triggered surface charge-switchable polymer micelles for the co-delivery of paclitaxel/disulfiram and overcoming multidrug resistance in cancer
Qiang Huo et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
Evgenia Karousou et al.
MATRIX BIOLOGY (2017)
MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers
Manu S. Singh et al.
PHARMACOLOGICAL RESEARCH (2017)
Folic Acid-Targeted Etoposide Cubosomes for Theranostic Application of Cancer Cell Imaging and Therapy
Yong Tian et al.
MEDICAL SCIENCE MONITOR (2017)
Development of Bioactive PEGylated Nanostructured Platforms for Sequential Delivery of Doxorubicin and Imatinib to Overcome Drug Resistance in Metastatic Tumors
Biki Gupta et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
Zhaolin Chen et al.
CANCER LETTERS (2016)
CS/PAA@TPGS/PLGA nanoparticles with intracellular pH-sensitive sequential release for delivering drug to the nucleus of MDR cells
Ying-Ying Wang et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles
Abdulaziz Almalik et al.
BIOMATERIALS (2013)
CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches
Karin Williams et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
Kinetics of MDR Transport in Tumor-Initiating Cells
Vasilij Koshkin et al.
PLOS ONE (2013)
Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors
Juan Carlos Montero et al.
CLINICAL CANCER RESEARCH (2011)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
分享论文
